Angelica Campbell said her daughter, Eliza, had a "horrendous" start to her life after she was diagnosed with an aggressive ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...

The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

China National Medical Products Administration (NMPA) has approved MSD’s KEYTRUDA for treating certain non-small cell lung cancer (NSCLC).

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

Doctors at Chesapeake Regional Healthcare are able to minimize the pain lung cancer patients undergo with a one-and-done ...

A popular Hawke’s Bay culinary arts teacher with a “really hard to kill” cancer is overwhelmed by the support, after his ...

Park (65, male), who recently retired after working for more than 30 years, continued to live a healthy life, enjoying ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...

During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no ...